Imatinib effect on Philadelphia chromosome positive acute lymphoblastic leukemia cells - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4175

Imatinib effect on Philadelphia chromosome positive acute lymphoblastic leukemia cells

Analysis of Ph+ ALL cell lines (BV-173, NALM-1, SUP-B15, and TOM1) treated with tyrosine kinase inhibitor (TKI) imatinib. Ph encodes oncogenic BCR-ABL1 tyrosine kinase, which defines a subset of ALL with an unfavorable prognosis. Results provide insight into TKI resistance mechanisms in Ph+ ALL.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 2 agent, 4 cell line sets

Platform:: GPL571
Series:: GSE23743
8 Samples

Download data: CEL

DataSet

Accession:: GDS4175

ID:: 4175

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Imatinib effect on Philadelphia chromosome positive acute lymphoblastic leukemia...
Imatinib effect on Philadelphia chromosome positive acute lymphoblastic leukemia cells
Accession: GDS4175

GEO DataSets
Related DataSets for GEO Profiles (Select 82873495) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets